ADALIMUMAB-ADBM
ADALIMUMAB-ADBM is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as human prescription drug products.
About ADALIMUMAB-ADBM
ADALIMUMAB-ADBM appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Boehringer Ingelheim Pharmaceuticals, Inc.. Approved labelling for these products most frequently references: adult patients, cyltezo indicated, reducing signs, moderately severely, years age, progression structural, improving physical, moderate severe. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing ADALIMUMAB-ADBM
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| Cyltezo | Boehringer Ingelheim Pharmaceuticals, Inc. | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products contain ADALIMUMAB-ADBM?
1 FDA drug label records list ADALIMUMAB-ADBM as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make ADALIMUMAB-ADBM products?
The manufacturers with the most ADALIMUMAB-ADBM label records are Boehringer Ingelheim Pharmaceuticals, Inc.. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.